These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23258810)

  • 1. Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study.
    Morales JM; Marcén R; del Castillo D; Andres A; Gonzalez-Molina M; Oppenheimer F; Serón D; Gil-Vernet S; Lampreave I; Gainza FJ; Valdés F; Cabello M; Anaya F; Escuin F; Arias M; Pallardó L; Bustamante J
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4(Suppl 4):iv39-46. PubMed ID: 23258810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease.
    Morales JM; Marcén R; Andrés A; Molina MG; Castillo DD; Cabello M; Capdevila L; Campistol JM; Oppenheimer F; Serón D; Vernet SG; Lampreave I; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
    Kidney Int Suppl; 2008 Dec; (111):S94-9. PubMed ID: 19034336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed graft function and its impact on the antigraft response after cadaver kidney transplantation].
    Rainiene T; Asakiene E; Zelvys A; Dainys B
    Medicina (Kaunas); 2005; 41 Suppl 1():101-6. PubMed ID: 15901985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results.
    Chamienia A; Dębska-Ślizień A; Król E; Biedunkiewicz B; Rutkowski B
    Transplant Proc; 2014 Oct; 46(8):2714-8. PubMed ID: 25380901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.
    González-Roncero FM; Gentil-Govantes MÁ; González-Molina M; Rivero M; Cantarell C; Alarcón A; Franco A; Sánchez-Plumed J; Lampreabe I; Lauzurica R; González E; Romero R; Ruiz-San Millán JC; Osuna A
    Nefrologia; 2012 Jul; 32(4):446-54. PubMed ID: 22806279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small kidneys for large recipients: does size matter in renal transplantation?
    Dinis P; Nunes P; Marconi L; Furriel F; Parada B; Moreira P; Figueiredo A; Bastos C; Roseiro A; Dias V; Rolo F; Alves R; Mota A
    Transplant Proc; 2015 May; 47(4):920-5. PubMed ID: 26036486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre case-control study.
    Moreso F; Alonso A; Gentil MA; González-Molina M; Capdevila L; Marcén R; Pascual J; Serón D;
    Transpl Int; 2010 Sep; 23(9):907-13. PubMed ID: 20230537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate outcomes of dual renal allografts: the University of Washington experience.
    Lee RS; Miller E; Marsh CL; Kuhr CS
    J Urol; 2003 Mar; 169(3):855-8. PubMed ID: 12576798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival?
    Rayhill SC; D'Alessandro AM; Odorico JS; Knechtle SJ; Pirsch JD; Heisey DM; Kirk AD; Van der Werf W; Sollinger HW
    Ann Surg; 2000 Mar; 231(3):417-23. PubMed ID: 10714635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes.
    Tremblay S; Kaiser TE; Alloway RR; Woodle ES; Diwan TS
    Prog Transplant; 2016 Jun; 26(2):183-90. PubMed ID: 27207408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic allograft dysfunction in kidney transplant recipients: long-term single-center study.
    Boratyńska M; Wakulenko A; Klinger M; Szyber P
    Transplant Proc; 2014 Oct; 46(8):2673-7. PubMed ID: 25380892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.